These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28290042)

  • 61. Inbuilt novel bioretardant feature of biopolymer isolated from
    Tyagi Y; Madhav NS
    J Drug Assess; 2020; 9(1):72-81. PubMed ID: 32341840
    [No Abstract]   [Full Text] [Related]  

  • 62. Preservation of rutin nanosuspensions without the use of preservatives.
    Stahr PL; Keck CM
    Beilstein J Nanotechnol; 2019; 10():1902-1913. PubMed ID: 31598456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes.
    Song Z; Yin J; Xiao P; Chen J; Gou J; Wang Y; Zhang Y; Yin T; Tang X; He H
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New curcumin-loaded nanocapsules as a therapeutic alternative in an amnesia model.
    da Costa Rodrigues K; da Silva Neto MR; Dos Santos Barboza V; Hass SE; de Almeida Vaucher R; Giongo JL; Schumacher RF; Wilhelm EA; Luchese C
    Metab Brain Dis; 2024 Apr; 39(4):589-609. PubMed ID: 38351421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insights on Development Aspects of Polymeric Nanocarriers: The Translation from Bench to Clinic.
    Tewari AK; Upadhyay SC; Kumar M; Pathak K; Kaushik D; Verma R; Bhatt S; Massoud EES; Rahman MH; Cavalu S
    Polymers (Basel); 2022 Aug; 14(17):. PubMed ID: 36080620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of plant-based emulsion formulations to control bacterial leaf blight and sheath brown rot of rice.
    Syed-Ab-Rahman SF; Carvalhais LC; Omar D
    Heliyon; 2020 Jan; 6(1):e03151. PubMed ID: 32042948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dual-Functionalized Pesticide Nanocapsule Delivery System with Improved Spreading Behavior and Enhanced Bioactivity.
    Cui J; Sun C; Wang A; Wang Y; Zhu H; Shen Y; Li N; Zhao X; Cui B; Wang C; Gao F; Zeng Z; Cui H
    Nanomaterials (Basel); 2020 Jan; 10(2):. PubMed ID: 32012747
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications.
    Ahire E; Thakkar S; Darshanwad M; Misra M
    Acta Pharm Sin B; 2018 Sep; 8(5):733-755. PubMed ID: 30245962
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
    Katara R; Sachdeva S; Majumdar DK
    Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarate.
    Soltani S; Zakeri-Milani P; Barzegar-Jalali M; Jelvehgari M
    Iran J Basic Med Sci; 2016 May; 19(5):550-60. PubMed ID: 27403262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation.
    Yadav SK; Mishra S; Mishra B
    AAPS PharmSciTech; 2012 Dec; 13(4):1031-44. PubMed ID: 22893314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design.
    B M; N A; S T
    Daru; 2010; 18(1):1-8. PubMed ID: 22615586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
    Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
    Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
    Bucolo C; Maltese A; Maugeri F; Busà B; Puglisi G; Pignatello R
    J Pharm Pharmacol; 2004 Jul; 56(7):841-6. PubMed ID: 15233861
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
    Pignatello R; Bucolo C; Puglisi G
    J Pharm Sci; 2002 Dec; 91(12):2636-41. PubMed ID: 12434408
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene.
    Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
    AAPS PharmSciTech; 2006 Mar; 7(1):E192-E198. PubMed ID: 28290042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
    Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
    AAPS PharmSciTech; 2006 Mar; 7(1):E27. PubMed ID: 16584158
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.